HopeStage
Back to all studies
UnknownNCT04771767

Combined Ketamine and eCBT Intervention for PTSD

Medication studyAges 18–65Canada
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

Listed locations
KingstonSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: August 1, 2021
Recruitment status
Unknown
Enrollment listed in the registry
16
Sponsor
Queen's University
Sponsor type
University
Study type
Drug
Intervention type
Behavioural, Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
Canada
Age range
From 18 Years to 65 Years
Official registry ID
NCT04771767
Official title
Show the full official title

Assessing a Combined Ketamine and Online Cognitive Behavioural Therapy Intervention for Treatment Resistant Post-Traumatic Stress Disorder

Recruitment & locations

Status unknown

Kingston

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Queen's University, a university.

Does this study involve medication?

Yes. The study involves medication, including ketamine.

Who can participate?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies